EC-17 clinical trials
Also written EC17 and Folate-FITC.
- studies test it
- 8
- open now
- 0
- in phase 3
- 0
- first study started
- 2005
How each study uses EC-17 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
8 studies that test it; most in 2013 (3)
| Year | Studies |
|---|---|
| 2005 | 1 |
| 2007 | 1 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 2 · Other 6
University of Pennsylvania (5) · Endocyte (2) · Mayo Clinic (1)
Often tested with
Tested in the same studies.
GPI0100 (2) · Keyhole limpet hemocyanin fluorescein labelled (1) · Interleukin-2 (1) · Interferon Alpha (1)
Studies
Open first, then newest update. How each study uses EC-17 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 8
- Intra-op Detection of Occult Ovarian Carcinoma Using a Folate-Alpha Receptor Specific Fluorescent LigandTerminatedPhase 2Mayo ClinicNCT01511055Written as EC-17
- Intraoperative Imagery of Breast Cancer With Folate-FITC (EC17)CompletedPhase 1University of PennsylvaniaNCT01994369Written as EC17
- EC17 for Intraoperative Imaging for ParathyroidectomyCompletedPhase 1University of PennsylvaniaNCT01996072Written as EC17
- Intraoperative Imagery of Renal Nodules With Folate-fluorescein Conjugate(EC17)CompletedEarly Phase 1University of PennsylvaniaNCT01778933Written as EC17
- EC17 for Intraoperative Imaging in Occult Ovarian CancerCompletedPhase 1University of PennsylvaniaNCT02000778Written as EC17
- Pilot and Feasibility Study of the Imaging Potential of EC17: Intraoperative Folate-fluorescein Conjugate (EC17) Lung Cancer (CA)CompletedPhase 1University of PennsylvaniaNCT01778920Written as EC17 imaging contrast agent
- Safety and Tolerability Study of FolateImmune in Combination With Cytokines in Patients With Refractory or Metastatic CancerCompletedPhase 1EndocyteNCT00329368Written as EC17 (Folate-FITC)
- A Phase II Study of EC17 (Folate-hapten Conjugate) in Patients With Progressive Metastatic Renal Cell CarcinomaTerminatedPhase 2EndocyteNCT00485563Written as EC17 (Folate-FITC)
Codes
What other systems call EC-17 · ClinicalTrials.gg INT018218
- UNII (FDA) V7YQ6134AEEC-17Confirmed FDA, Wikidata
- Wikidata Q27291646ec-17Confirmed FDA, Wikidata
- DrugBank DB12559One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | V7YQ6134AE | EC-17 | Confirmed FDA, Wikidata |
| Wikidata | Q27291646 | ec-17 | Confirmed FDA, Wikidata |
| DrugBank | DB12559 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.